Osteoarthritis (OA) is the most common degenerative joint disease, and joint injury increases the risk of OA by 10-fold. Although the injury event itself damages joint tissues, a substantial amount of secondary damage is mediated by the cellular responses to the injury. Cellular responses include the production and activation of proteases (MMPs, ADAMTSs, Cathepsins), the production of inflammatory cytokines, and we hypothesize, changes to the joint metabolome. The trajectory of cellular responses is driven by the transcriptional activation of early response genes, which requires Cdk9-dependent RNA Polymerase II phosphorylation. Flavopiridol is a potent and selective inhibitor of Cdk9 kinase activity, which prevents the transcriptional activation of early response genes. To model post-traumatic osteoarthritis, we subjected mice to noninvasive ACL-rupture joint injury. Following injury, mice were treated with flavopiridol to inhibit Cdk9-dependent transcriptional activation, or vehicle control. Global joint metabolomics were analyzed 1 hour after injury. We found that injury induced metabolomic changes, including increases in Vitamin D3 metabolism and others. Importantly, we found that inhibition of primary response gene activation at the time of injury largely prevented the global changes in the metabolomics profiles. Cluster analysis of joint metabolomes identified groups of injury-induced and drug-responsive metabolites, which may offer novel targets for cell-mediated secondary joint damage. Metabolomic profiling provides an instantaneous snapshot of biochemical activity representing cellular responses, and these data demonstrate the potential for inhibition of early response genes to alter the trajectory of cell-mediated degenerative changes following joint injury.
as IL1, IL6, iNOS, and TNF from the joint tissues(12). This, 22 in turn, causes the transactivation of primary response genes 23 and leads to the production of matrix-degrading enzymes such 24 as MMPS, Cathepsins, Collagenases, Aggrecanases, and the 25 production of inflammatory cytokines. The transactivation of 26 the primary response genes thus constitutes a secondary wave 27 of cell-mediated damage, which contributes substantially to 28 the elevated risk for OA by causing irreversible damage at the 29 molecular level(13). 30 The transcriptional activation of primary response genes is 31 regulated by the kinase activity of cyclin-dependent kinase 9 32 (Cdk9). The majority of primary response genes are 'primed' 33 for rapid transcriptional activation, with the transcription 34 complex already assembled on the DNA promoters and the 35 RNA polymerase complex stalled just before entering the 36 transcriptional elongation stage. The rate-limiting step for 37 the transcription of primary response genes is the recruit-38 ment of Cdk9, which then phosphorylates RNA Polymerase II 39 to enable transcription to proceed. This central mechanism 40 of regulation is highly conserved amongst primary response 41
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genes(14-18). Importantly, because RNA Polymerase II it-42 self is the target for Cdk9 kinase, this regulatory mechanism 43 is largely independent of the actual primary response gene 44 being transcribed (18) (19) (20) . Furthermore, multiple signaling 45 pathways converge on Cdk9 kinase activity to initiate pri- The entire injury takes under 2 seconds, and since this injury 94 is a non-invasive method, it enables the study of the natural 95 progression of the acute injury responses, including changes 96 in gene expression and metabolite concentrations.
97
To assess functional changes in molecular biology related to 98 joint injury, metabolites were extracted from micro-dissected 99 joint tissue following injury. For injured mice, we found dis-100 tinct metabolomic profiles between the injured right joints Mirrored distributions plotted as median mass spectra from n = 6 mice. Injured knee plotted on top in black and uninjured knee plotted on bottom in gray. (B) Scatter plot comparing metabolite expression levels. There were 81 metabolites exclusively detected in uninjured control knees (red) and 66 metabolites exclusively detected in injured knees (blue). (C) Clustered heatmap of median metabolites between control and injured mouse knees. There were 822 metabolites detected in both control and injured joints. We identified two clusters of interest. (D) Cluster 1 includes 35 metabolites with decreased expression in injury, including glutamine. Cluster 2 contains 47 metabolites with increased expression in injured knees compared with uninjured knees. Cluster 2 includes a vitamin D3 derivative and anandamide. For panel D, all metabolites significantly different with all p < 0.01 using statistical comparison #2. and contralateral uninjured left joints ( Figure 1A ). There were 102 66 metabolites detected in the injured knees that were not 103 detected in the contralateral uninjured joints, and 81 metabo-104 lites detected in the contralateral uninjured joints that were 105 undetected in the injured joints ( Figure 1B) . Overall, there 106 were 132 metabolites upregulated and 131 metabolites down-107 regulated in injured joints compared with the contralateral 108 uninjured joints of the same mice. Two clusters of interest were 109 identified in hierarchical cluster analysis (HCA), with cluster 110 1 containing 35 metabolites downregulated with injury and 111 cluster 2 with 47 metabolites upregulated with injury (Figure 112 1A). Within these clusters, we identified several metabolites 113 differentially regulated by injury, including upregulation of 114 anandamide and downregulation of glutamine ( Figure 1C -D). 115 We found substantial upregulation of metabolites related to vi-116 tamin D3 signaling in injured joints ( Figure 1D ). We observed 117 downregulation of deoxycytidine triphosphate consistent with 118 injury-induced upregulation of primary response genes (Figure 119 1D). Enrichment analysis revealed that glutamine and gluta-120 mate, arginine and proline, and pyrimidine metabolism were 121 downregulated after injury. Pathways upregulated after in-122 jury included retinoid metabolism, phospholipid biosynthesis, 123 hydroxyproline degradation, and anandamide metabolism. Following injury, a group of mice was treated with the Cdk9 126 inhibitor flavopiridol to downregulate transcription of early re-127 sponse genes. Early response genes are associated with inflam-128 mation and degradative enzymes, which can lead to long-term 129 joint damage. We observed distinct metabolomic profiles be-130 tween joints of injured mice and joints of injured mice treated 131 with flavopiridol (FP, Figure 2 ). The metabolomic profiles of 132 injured joints treated with FP were more similar to control 133 joints than to injured joints without treatment. In injured 134 joints, there were 56 metabolites detected after FP-treatment 135 that were not detected in untreated joints. In contrast, in 136 injured joints there were 98 metabolites detected in untreated 137 joints that were not present after FP-treatment. Treatment 
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Within the pentose phosphate pathway, there are two re-154 actions that convert NADP + to NADPH. Injury upregulated 155 the ratio of NADPH to NADP + , consistent with the tran-156 scription of early response genes ( Figure 3B ). Treatment with 157 flavopiridol was able to reduce this injury-induced upregulation. 158 Injury also upregulated the ratio of ATP to ADP indicating 159 increased glycolysis ( Figure 3C ). Flavopiridol-treated mice had 160 a higher ratio of ATP to ADP suggesting increased glycolytic 161 metabolism upon inhibition of early response genes. The ratio of NADP + to NADPH was larger in the con-163 tralateral control joints than injured joints ( Figure 3D ), which 164 was driven by increases in NADPH expression in the injured 165 joint (Supplemental Figure S1 ). The ratio of ADP to ATP 166 was increased in injured knees compared with contralateral 167 controls, and this increase was accentuated via treatment with 168 flavopiridol. The ratios of NAD+ to NADH and GDP to 169 GTP were largely unchanged by injury. Taken together, these 170 results indicate that injury decreases glycolytic metabolism 171 with a concomitant increase in carbon metabolism via the 172 after injury. These injury-induced increases are likely due to 233 the bone remodeling caused by the mechanical overload. Fur-234 thermore, the flavopiridol-induced reduction in phylloquinone 235 levels may further suggest that transcription of early response 236 genes mediates bone remodeling after injury.
237
Acetylcarnitine was upregulated in the joint after injury. 238 Acetylcarnitine is metabolized to carnitine, which transports 239 fatty acids to the mitochondria for breakdown. We also iden-240 tified fatty acid transport and various lipid metabolism path-241 ways upregulated after injury. Lipids and fatty acids have 242 previously been implicated in chondrocyte mechanotransduc-243 tion, although their importance in OA pathogenesis remains 244 unknown(35). Levels of acetylcarnitine were abrogated with 245 flavopiridol treatment, which may suggest that transcription 246 of early response genes may be mediating injury-induced per-247 turbations in fatty acid metabolism. Previous studies have 248 also investigated the prophylactic role of acetylcarnitine in a 249 monosodium iodoacetate rat model of OA, demonstrating that 250 acetylcarnitine supplementation was able to reduce overall OA 251 damage in the joint and attenuate OA pain(36). Flavopiridol 252 treatment, however, did abrogate the increase in acetylcar-253 nitine levels in this study, which could suggest a potentially 254 negative side effect of inhibiting the transcription of early 255 response genes after injury. Further studies are needed to 256 elucidate the role of fatty acid metabolism and acetylcarnitine 257 levels after injury and its implications for the development of 258 PTOA.
259
Anandamide levels and anandamide metabolism were up-260 regulated after joint injury. A likely source of anandamide 261 in joints is synovial fibroblasts because these cells contain 262 the required enzymes for its synthesis(37). Elevated levels 263 of anandamide have previously been found in synovium and 264 synovial fluid from patients with end-stage OA(38). Anan-265 damide is an endocannabinoid implicated in inflammation, 266 pain, nociceptive signaling, and analgesia via cannabinoid 267 receptors. Importantly, elevated levels of anandamide after 268 injury are thought to modulate the intensity of pain stim-269 uli. Genes required for anandamide synthesis are induced 270 by LPS within 90 minutes(39), but to our knowledge they 271 have not been studied specifically as Cdk9-dependent primary 272 response genes. Our results support increased anandamide 273 levels after injury. However, additional studies are needed to 274 elucidate anandamide's role in injury-induced pain signaling. 275 Anandamide also has known roles in osteoclast and osteoblast 276 activation and proliferation(40, 41). Taken together with the 277 subchondral bone remodeling after ACL rupture in this model, 278 the increased levels of anandamide after injury may also sug-279 gest a role in injury-induced bone remodeling. Consistent with 280 previous findings, these results suggest that elevated anan-281 damide levels are associated with injury and may be playing a 282 role in injury-induced bone remodeling and/or pain signaling. 283
Targeted metabolomics found several changes in central 284 energy metabolism following joint injury. The flux through 285 the pentose phosphate pathway, as quantified by decreases in 286 the ratio of NADP + to NADPH increased after joint injury. 287 This increase is likely due to the increased requirement for 288 nucleobases to transcribe early response genes. As expected, 289 this flux increase was abrogated following Cdk9 inhibition via 290 flavopiridol treatment. Similarly, glycolytic flux, quantified by 291 decreases in the ratio of ATP to ADP decreased following joint 292 injury. We found no changes in the TCA cycle represented 293 (Table I) . The left and right legs of the uninjured/control mice 383 were not subjected to injury. For the injured mice, the right leg 384 was subjected to joint injury, whereas the left leg served as a 385 sham control, and was not subjected to injury. For the injured + 386 flavopiridol mice, the right leg was subjected to injury and the left 387 leg served as a sham control and was not subjected to injury. The 
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